NEW YORK (GenomeWeb News) – Biofield today said that it has licensed exclusive worldwide distribution rights, outside of Belgium, to ValiRx's human papillomavirus diagnostic test as well as its HyperGenomics and Nucleosomics cancer diagnostic products.

The products are being developed by ValiBio, a Belgian joint venture between the UK's ValiRx and the Institut de Pathologie et de Genetique, which houses ValiBio's operations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.